The Arteriovenous Malformations Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the arteriovenous malformations market has seen significant growth recently. The market size is forecasted to increase from $2.88 billion in 2024 to $3.11 billion in 2025, representing a compound annual growth rate (CAGR) of 7.7%.
The arteriovenous malformations market is forecasted to reach a size of $4.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Arteriovenous Malformations Market Report and Uncover Key Trends Now!The key drivers in the arteriovenous malformations market are:
• Rising use of gene therapy
• Increasing demand for advanced medical technology
• Growing demand for quality healthcare
• Increasing consumption of neurological drugs and growth with the aging population
The arteriovenous malformations market covered in this report is segmented –
1) By Type: True Arteriovenous Malformation, Occult Or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Other Types
2) By Diagnosis: Physical examination, Brain Scans, Other Diagnosis
3) By Treatment: Endovascular Embolization, Neurosurgery
4) By Age Group: Adult Patients, Pediatric Patients
5) By End-User: Hospitals And Clinics, Research laboratories, Other End-Users
Subsegments:
1) By True Arteriovenous Malformation Type: Pial AVMs, Spinal AVMs, Brain AVMs, Extremity AVMs, Visceral AVMs
2) By Occult or Cryptic Type: Micro-AVMs, Hidden AVMs, Asymptomatic AVMs, Deep-Seated AVMs, Small-Scale AVMs
3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs), Spinal Cavernous Malformations, Familial Cavernous Malformations, Solitary Cavernous Malformations, Multiple Cavernous Malformations
4) By Venous Malformation Type: Superficial Venous Malformations, Deep Venous Malformations, Mixed Venous Malformations, Syndromic Venous Malformations, Blue Rubber Bleb Nevus Syndrome
5) By Hemangioma Type: Infantile Hemangiomas, Capillary Hemangiomas, Lobular Capillary Hemangiomas, Cavernous Hemangiomas, Compound Hemangiomas
6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF), Spinal Dural Arteriovenous Fistula, Direct Dural AV Fistula, Indirect Dural AV Fistula, High-Flow Dural Fistula
7) By Other Types: Lymphatic Malformations, Mixed Vascular Malformations, Arteriovenous Aneurysms, Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs, Rare Congenital AVMs
The key trends in the arteriovenous malformations market are:
• Gene therapy usage is increasing in arteriovenous malformations management.
• Medical technology advancements are driving evolution in the arteriovenous malformations market.
• Microsurgical techniques advancements are gaining prominence.
• Innovations in catheter technology are a significant trend.
Major players in the arteriovenous malformations market are:
• Johnson And Johnson Services Inc.
• Siemens AG
• Medtronic Plc
• Koninklijke Philips N V
• Stryker Corporation
• GE Healthcare Technologies Inc
• Cedars-Sinai
• Penn Medicine
• Terumo Corporation
• Eisai Co Ltd
• Cook Medical LLC
• Elekta AB
• Merit Medical Systems Inc.
• Penumbra Inc.
• Max Healthcare
• RWJBarnabas Health
• Balt LLC
• Booking Health GmbH
• Duke University Health System
• Shape Memory Medical Inc.
North America was the largest region in the arteriovenous malformations market in 2024